Evidence map›Paper›PMID 34193448›Full record

ArticleBMJ case reports2021

Aggressive angiomyxoma of left buttock.

Hassan Akram, Deanna Tran, Rafey Rehman, Zaid Al-Wahab

Open access · greenAbstract readCase Reports
In one paragraph

Article in BMJ case reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Hassan AkramDepartment of Gynecologic Oncology, Beaumont Health, Royal Oak, Michigan, USA hakram@oakland.edu.
Deanna TranDepartment of Gynecologic Oncology, Beaumont Health, Royal Oak, Michigan, USA.ORCID http://orcid.org/0000-0001-9539-6375
Rafey RehmanDepartment of Gynecologic Oncology, Beaumont Health, Royal Oak, Michigan, USA.
Zaid Al-WahabDepartment of Gynecologic Oncology, Beaumont Health, Royal Oak, Michigan, USA.
Beaumont Health · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aggressive angiomyxoma (AA) is a rare mesenchymal tumour that is characterised by increased incidence in women compared with men, local invasion to the surrounding tissue and high recurrence rate. A premenopausal woman presented to clinic with pelvic pressure, intermittent tingling in the thigh and pressure emptying the bladder. CT scan, vaginal and gluteal biopsies, and MRI scan were performed to conclude a final diagnosis of AA. The patient underwent complete resection of the mass. The mass tested positive for oestrogen receptor and progesterone receptor. The patient received leuprolide postoperatively to prevent recurrence. AA should be considered as a differential diagnosis for a pelvic and perineal mass. Patients should be warned of high recurrence rate, necessity of surgical removal and long-term hormonal treatment.

Indexed as

MyxomaNeoplasm Recurrence, LocalButtocksFemaleHumansMagnetic Resonance ImagingMaleReceptors, EstrogenReceptors, Estrogencancer interventioncancer - see oncologygynecological cancerobstetrics and gynaecology

Identifiers

PMID34193448
PMCPMC8246281
OpenAlexW3176493154

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.